34 results on '"Fiandor, Jose M."'
Search Results
2. Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition
3. Short-course combination treatment for experimental chronic Chagas disease
4. Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis
5. Discovery of pyrazolopyrrolidinones as potent, broad-spectrum inhibitors of Leishmania infection
6. Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis
7. Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis
8. Identification and Optimization of a Series of 8-Hydroxy Naphthyridines with Potent In Vitro Antileishmanial Activity: Initial SAR and Assessment of In Vivo Activity
9. Identification of 6-amino-1H-pyrazolo[3,4-d]pyrimidines with in vivo efficacy against visceral leishmaniasis
10. Metabolic clustering analysis as a strategy for compound selection in the drug discovery pipeline for leishmaniasis
11. Cyclin-dependent kinase 12, a novel drug target for visceral leishmaniasis
12. Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi
13. Identification and Optimization of a Series of 8-Hydroxy Naphthyridines with Potent In VitroAntileishmanial Activity: Initial SAR and Assessment of In VivoActivity
14. Identification of 6-amino-1H-pyrazolo[3,4-d]pyrimidines with in vivoefficacy against visceral leishmaniasisElectronic supplementary information (ESI) available. See DOI: 10.1039/d0md00203h
15. Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi
16. New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource
17. Potent antimalarial 4-pyridones with improved physico-chemical properties
18. Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis
19. Corrections to Falcipain Inhibitors: Optimization Studies of the 2-Pyrimidinecarbonitrile Lead Series
20. Falcipain Inhibitors: Optimization Studies of the 2-Pyrimidinecarbonitrile Lead Series
21. ChemInform Abstract: Antifungal Sordarins. Part 3. Synthesis and Structure-Activity Relationships of 2′,3′-Fused Oxirane Derivatives.
22. Antifungal Sordarins. Part 4. Synthesis and Structure—Activity Relationships of 3′,4′‐Fused Alkyl‐tetrahydrofuran Derivatives.
23. ChemInform Abstract: Antifungal Sordarins. Synthesis and Structure—Activity Relationships of 3′,4′‐Fused Dioxolane and Dioxane Derivatives.
24. ChemInform Abstract: Stereoselective Synthesis of the Antifungal GM222712.
25. Corrigendum to “Potent antimalarial 4-pyridones with improved physico-chemical properties” [Bioorg. Med. Chem. Lett. 21 (2011) 5214–5218]
26. Antifungal sordarins. Part 4: synthesis and structure–activity relationships of 3′,4′-fused alkyl-tetrahydrofuran derivatives
27. Antifungal Sordarins. part 3: synthesis and structure–Activity relationships of 2′,3′-Fused oxirane derivatives
28. Antifungal sordarins. Synthesis and structure–activity relationships of 3′,4′-Fused dioxolane and dioxane derivatives
29. An improved two-resin method for the cleavage of tertiary amines from REM resin
30. Stereoselective synthesis of the antifungal GM222712
31. Stereocontrolled glycosylation of sordaricin in the presence of ammonium salts
32. ChemInform Abstract: Antifungal Sordarins. Part 3. Synthesis and Structure-Activity Relationships of 2′,3′-Fused Oxirane Derivatives.
33. Identification of 6-amino-1 H -pyrazolo[3,4- d ]pyrimidines with in vivo efficacy against visceral leishmaniasis.
34. Metabolic Clustering Analysis as a Strategy for Compound Selection in the Drug Discovery Pipeline for Leishmaniasis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.